Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

    NEXT STORY
    Basilea reports marketing authorization of antifungal Cresemba® in Brazil
    PREV STORY
    Editas Medicine Appoints Judith R. Abrams, M.D., as Chief Medical Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sorrento Announces Dr. Robin Smith as New Member of the Board of Directors

    author_avatar
    NASDAQ Market News

    IMV Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference

    HALIFAX, Nova Scotia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: ...

    author_avatar
    NASDAQ Market News

    New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 Presented by Aptevo Therapeutics and Alligator Bioscience at Prominent Industry Conferences

    ALG.APV-527 is Designed to Strategically Target and Engage the Immune System for the Potential Treatment ...

    author_avatar
    NASDAQ Market News